Nature's Sunshine Products (NATR) investor relations material

Company overview and heritage

• Founded in 1972, the company pioneered encapsulated herbal supplements and built a legacy of quality and innovation in natural health products.

• Operates globally with tens of thousands of independent consultants and two main brands, selling in over 40 countries.

• Manufactures over 90% of products in-house, holding top certifications and maintaining a strong balance sheet with no debt.

• Leadership team combines industry veterans and new talent, recently appointing a new CFO with global consumer experience.

Strategic growth vision and financial performance

• Aims to double sales to $1 billion and improve EBITDA margin to 15% through scale and leverage.

• Outperformed industry peers with 4% annual top-line growth and 16% EBITDA growth over four years.

• Delivered shareholder returns more than twice the Russell 2000 index since 2023.

• Growth strategy centers on geographic expansion, digital channel growth, superior marketing, and M&A.

Geographic and channel expansion

• Expanding within existing markets by opening new offices in cities like Fukuoka, Japan, and targeting other urban centers in Korea and China.

• Entered Germany, the largest supplement and direct selling market in Europe, and plans to launch in a new Asian country pending approvals.

• Sees significant U.S. growth potential for the Synergy brand, planning to market both brands in parallel.

• Digital direct-to-consumer business has grown rapidly, reaching $50 million in sales, with plans to expand into larger retail chains.